Hoersholm; August 07, 2014 - Medical Prognosis Institute A/S (NASDAQ:MPI) announces that the scheduled publication date of its H1 report 2014 will advanced from August 26, 2014 to August 12, 2014. For further information please contact CEO Peter Buhl Jensen, Professor, MD, PhD E-mail: pbj@medical-prognosis.com Cell Phone: (+45) 21 60 89 22 Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark [HUG#1847213]
MPI advances the date for publication of its scheduled H1
Top 10 Most Recent News Articles
AI Memory Growth Pushes Limits at GMIF2026 Summit
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
DKS Facing Class Action Over Stock Slump Allegations
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue ReadingTop 5 Most Recently Viewed Articles
Solstice Advanced Materials Expands Uranium Conversion Capacity
Exciting Expansion at Solstice Advanced Materials In response to the surging demand for nuclear energy, Solstice Advanced Materials is making significant moves to expand its production capabilities in uranium conversion. The company is set to produce over 10 kilotonnes of uranium hexafluoride (UF?) in 2026, which would mark a notable 20% increase from what was planned for...
Continue Reading
Oragenics, Inc. Announces Public Offering Pricing Details
Oragenics, Inc. Announces Public Offering Pricing Oragenics, Inc. (NYSE American: OGEN), a biotechnology firm based in Sarasota, Florida, is making headlines with its latest public offering. The company specializes in innovative intranasal treatments designed for neurological disorders and has entered into a placement agreement to sell over 8 million shares of its common...
Continue Reading
Ongoing Securities Investigation of America's Car-Mart, Inc.
Overview of the Investigation into America's Car-Mart, Inc. America's Car-Mart, Inc. (NASDAQ: CRMT) has become the focus of increasing scrutiny due to allegations of possible violations of federal securities laws. Investors, particularly those who may have incurred financial losses, are encouraged to stay informed about recent developments. The investigation aims to...
Continue Reading
Land's End Reports Q2 Results, Investors Remain Cautious
Land's End's Recent Financial Performance Overview Apparel company Land's End Inc (NASDAQ: LE) recently reported its financial results for the second quarter, which fell short of analysts' expectations, causing its stock to decline. With a revenue figure of $294.1 million, the company experienced a 7.3% decrease compared to the same period last year. Sales Decline and Its...
Continue Reading
Ridgeline Construction Honored as Silver Small Business Leader
Ridgeline Construction's Recent Achievement Woman-owned, GAF Master Elite contractor recognized for civic leadership and business excellence among state's top-performing small businesses Ridgeline Construction Roofing & Exteriors has achieved recognition as a Silver Award winner in the 11–50 Employees category at the Alabama Small Business of the Year Awards. This...
Continue Reading